pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-628 |
Genomic Coordinates | chr15: 55372940 - 55373034 |
Synonyms | MIRN628, hsa-mir-628, MIR628 |
Description | Homo sapiens miR-628 stem-loop |
Comment | The mature sequence shown here represents the most commonly cloned form from large-scale cloning studies . |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-628-3p | ||||||||||||||||||||||||||||
Sequence | 61| UCUAGUAAGAGUGGCAGUCGA |81 | ||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||
Experiments | Microarray | ||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
DRVs in miRNA |
|
||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | BTF3L4 | ||||||||||||||||||||
Synonyms | - | ||||||||||||||||||||
Description | basic transcription factor 3 like 4 | ||||||||||||||||||||
Transcript | NM_001136497 | ||||||||||||||||||||
Other Transcripts | NM_152265 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on BTF3L4 | |||||||||||||||||||||
3'UTR of BTF3L4 (miRNA target sites are highlighted) |
>BTF3L4|NM_001136497|3'UTR 1 AAGTTTGGTTTTTGGAAGCTGGCATGGACTAGATTTAACAAATCAGCTATGTGGTTCCAAAGTTTTACAGACATGGAGAA 81 CATCACCTGTTACTAGTTCAGTAATATAAATATTTTGTATATTAATAATGCTGTTTGTTCAGCATTTTTCGGTCATTTGA 161 TTTTGCATTTTGCACTTCCTCCCAGGATATTTTTTTGGTCAAAATATGAAGTATTGGTGCAGTTTGAGGGTGTTTTGGTT 241 TTTGATTCCTGGTTTTTTTGTTTTTTGTTTGGGGTATTTTTGGTGTATGTATGTTTATGTATGTGTGTGGGTATGTGTGT 321 ATACAGTGGAGAGCAAATTGGAAAACAGTTCTATTTATCCTCCTCCCTCCCCAGTAGAAATAAAAAAAATCTTTACATTT 401 GTTACTTTTCTTTTCCCCCCGTAAGACACAGAATTAATGGAAAGTGAGTATCTTGGATTTCAAATCTGAAGAGATTTTTA 481 CCATTAGTGGTTTGATTTTAATTTGCTTGGTTAACTATCATATTTTTCATACACTTCTCTGGATTTAAAATATCTTGAGG 561 TATTTTGCCACTGGCTTCATGCTGGAGTAATGGGTAACATATCTTTGGTATGGTTGCCTTAGATTAACTTACCTAGTCAG 641 ACCCAGAAGAACTTCTTTTACTAGCTTGCTTCCTAAATGCCTTTTTTCCTCTCCTTTTGGTCTCCAAATGGCCTGGTCAG 721 CTTTTGGTAATATTCTTCCTCATCTTCCACCTAGCTTGAGAAGGATGTTCTCCATATAGAGTTTAGCGAGTGCCTAATCC 801 CTCCTTTTGTAAGATTTTGTTCCCTCAGCTTGAGGAACAACTTCATCTTCAACTTTTTATTTCTCCCTGATGTTACAGTT 881 TGGTAGATTTCAAACTGGAATAGCTAGCATGTGCTTGCTAAATAATTTTATGCCAGCCTTATCCTGTATCCTAGCTGTTC 961 TTAACAGCAGGTACAAAAATGCCTGTTTTTCAGCAAGGTTGAAATTGGGAATGTCCTTTTGAATCAGAAGAAAATAGGCC 1041 ATAGACTCATCTCCCAGCACAAATGGGCATTCTATGAAATGGTACTGGCCCTAGGAGGATTTCCTCAACCACTCTCCTAC 1121 TCTTGGCCTTGAACCTACCTCTGGGTTGGATCTTACTATTGTAGCTGCTCACTATACCCTCCTGCATGCTTAGAATAATG 1201 CTTTGAGGGGAGCACTGGTAAAACACAGTATTTATTTTTTTACCTCCTTTAAGAGGACTTGGAGGTAAGTTGCATTCATT 1281 CACTCAAGTTTCCCTCTTGCTGTCTAATAGAAGCTTACTTTTTGCTATATCAGCATTTGTTACAGCCAATATTTAAGGAC 1361 AAAATTTAGAAAATATATCATTTCCTGGCCCATCATCAAACTAATACAGCTTAACCTTGCAGCTACCAACTTTTGTGTCA 1441 AGCTAGATATCTTTATTTGATATCTAAGGTGCAAGACCAACAATATATTAAGAGATCTGTAGACATGAAGGCAAAGCTCT 1521 TGTATTTTTTTTCATCCAAACACCTCAATTTATTTTATAAATTCGTTCATTTTTCCTGTTATGTTTTATATAATATATGG 1601 ACTAAACAAAATAAAATAACAGTGCAAAAGAGGAGAATATTTCCTCTTGTGCTTTTCTTGATGTTGTGTACAGAATTTCC 1681 TTTTATATTATTCCTCTACCCTCCACCTGTAAATGAATGTTAGTGCAGTAATTGTTTGAAATAATGCCTCATCCAGTGTT 1761 AGGTCAGTAGCTCCACAGTCTACACAGTCCAGAATTCTTTCTCTAATTGTCCCAAAGGGGGACATTGTGGAGGCAGAGTT 1841 AGGGGGAACCACTTCAAGTGGTTAGGGACAGATAAATAATAGGCAGTATAGCACATGAAAGAAAACACACACTTGGAAGC 1921 CAGGAGACTTGTGTCCTAGTCAAAACTCTGGCATTATGTGACCTTGGACAGGTCATCTAACTACTCTGAAATTTATCATC 2001 AGTCAAATAAGATTTTATTCTGTTTTGTTTTGTTTGAGATGGGGATTTGCTCTTGTTGTCCAGGCCGAACTGCAATGTTG 2081 TGGTCTCGGCTGACTGCAACCTCCACCTCCCAGATTCAAGCGATTCTCCTGTCTCAGCCTCCACAGTAGCTGGGATTTTT 2161 TTTTTTTTTTTTTGTATTTTTAGTAGAGATGGGGTTTTACCATGTTGCCCAGGCCGGTCTTGAATTCCTGTCCTCAGGTG 2241 ATTCATTTGCCTCGGCCTCCCAAAGTGCTAGGATTACAGGCGTGAGCCACTGCACCCAGCCCAAATGAGATGTTTCTAAA 2321 TCTAAAGTTTCTTCTGCTTCTGCATTTCTGTGAATCTCATTTGAAATTTTTCAGGGAAGGGATTTTATCATTTGTTCAGA 2401 GATGTCTTTATTTTTATTAATACCCATAAAACGTTTGTGTATTTGCTTCTTCCTCTTTCTCCTTTTGATCACATTTTAGC 2481 TACTTATCTAGAGGATCTCTGGCCAAGTATTCCCTTTTATTGTATTGATAACAATTCTTAATGGCTGGCCTCTCTTGTGT 2561 ACAATGAGCCAATATTCTTTTTTGTTCTATATTTTTGTATCTTCCCCTTTCCTGAACAAAGCATATTTAGAGTCTCAAAG 2641 AAATCCTCTCCACAAAGACATGTTCCTCCCTCTGGTGTGGGTAGACATAGGGTAAGAGTTTGGATGAAACTTTTGTAAAT 2721 TGTAGTGTTCTTGGCATAAATATGAATTAAATCTTTTTTTATATTTAAATAACTAGTTAAATATGTGCTTCTTACTAAGA 2801 TTAGGTATTTTTTGCCAAGATAACAATGATAAAAACATTTTGGGGGGGAAATTGACCTTAAAATTTTGGGATAATTCAAG 2881 AAATGTCTGCAGAAAATTGATTTATGATCTTAATTTTTGTGTTAGTCCTTTGAGGTTTTTTTGTTTTTGTTTTTGTTCTT 2961 TGTAAAGCGCCTTATCTGTTTTGGACAAGTCCAAAGTAAATGGTTGGGCTCTTATATCTGTTTTACCCTTATTTTTCCCA 3041 TTAAGTAATGGTTTAAGAATATATCAAGCACCTTAATTTGTTGTTAAGTAGCTAGTGCTTACAGGATTCCATTAAATTCA 3121 CTTTAATAAGCCTATGAAGTTCTTATGAAAAACCCATATCTGCGATATGTTTGATTTGTTTCTTTGTTTTAATTCAGTGT 3201 TTAACCCTAGGTATGCTACATACCCATAAATAAGATACCATGGTAAGAGATAGTATGTTATAGTGGGAAAAGCACAAGTT 3281 TTTAGATAGAGATCAATTCTGCTATCTACCCTTACATTGTAACCTTTCTGACAGGGCTGCTGCGGTGCACAACTTCGGGA 3361 GCCATCACTTATTTTTGTTGTGTTCCAGAAGGTGTCATTTTCATAGACTGCAGTGTGAATAGTGTCCTCCATTAATAATG 3441 CAATGATGGCCTTGCTCTCTGAGCCTCAGTTTTATCTATAAAATGGTACCTAGAAGAGTCATGATTTCTTAGAATCCCCT 3521 AAATTATTAAGGTGAAGGTAGAAGATGATTAAAGCGTGTTATCTCCTAAGCTATGGCTTAGATTTTCCGAAGCTCATGGT 3601 TCTAGGCACAGAAAGTCTCCATTCTACACTGCATTTCAACCTGTGTTGAACAACACTCCAGTTCAGCCTGTATTGCTATG 3681 CCACATAGAGTTTGCCTGAATTATTATAGCTTTCTTAATAGTTTTGTTTATGATCCACTCTCTCCAGCCCATTACACAGG 3761 AGCCAGCTACCTAAATTTCCTATCTGAGCATGTCCTTACATTTACTTCCAGCATACTATTCATTTGCCATAGTAGAGTAT 3841 TAAGATTATTTGATTTTCTTTTTACTTTCTCGTAGTGCCCAATGTGTAGTTTACTCAACATCATAATATGTAATGTTTTT 3921 CAACTACTTACTGTTGAATACAAAGTTATCTCATTTAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection
PAR-CLIP data was present in GSM545217. RNA binding protein: AGO2. Condition:miR-7 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
CLIP-seq Support 1 for dataset GSM545216 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-124 transfection |
Location of target site | ENST00000489308.2 | 3UTR | ACAUGGAGAACAUCACCUGUUAC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM545217 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-7 transfection |
Location of target site | ENST00000489308.2 | 3UTR | ACAUGGAGAACAUCACCUGUUAC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
27 hsa-miR-628-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT039584 | CDC14A | cell division cycle 14A | 1 | 1 | ||||||||
MIRT039585 | AGO1 | argonaute 1, RISC catalytic component | 2 | 3 | ||||||||
MIRT039586 | TGFBRAP1 | transforming growth factor beta receptor associated protein 1 | 1 | 1 | ||||||||
MIRT039587 | LRP6 | LDL receptor related protein 6 | 1 | 1 | ||||||||
MIRT071876 | BTF3L4 | basic transcription factor 3 like 4 | 2 | 2 | ||||||||
MIRT097443 | JMY | junction mediating and regulatory protein, p53 cofactor | 2 | 4 | ||||||||
MIRT100100 | ABT1 | activator of basal transcription 1 | 2 | 8 | ||||||||
MIRT147692 | CBX4 | chromobox 4 | 2 | 2 | ||||||||
MIRT408248 | PURA | purine rich element binding protein A | 2 | 2 | ||||||||
MIRT442047 | LRAT | lecithin retinol acyltransferase | 2 | 2 | ||||||||
MIRT444412 | RAB3IP | RAB3A interacting protein | 2 | 2 | ||||||||
MIRT452599 | REPIN1 | replication initiator 1 | 2 | 2 | ||||||||
MIRT469515 | RBFOX2 | RNA binding protein, fox-1 homolog 2 | 2 | 8 | ||||||||
MIRT498192 | AKR1B10 | aldo-keto reductase family 1 member B10 | 2 | 2 | ||||||||
MIRT500151 | CREBBP | CREB binding protein | 2 | 2 | ||||||||
MIRT507319 | FAM60A | SIN3-HDAC complex associated factor | 2 | 6 | ||||||||
MIRT508343 | ZNF273 | zinc finger protein 273 | 2 | 6 | ||||||||
MIRT520480 | TRIM13 | tripartite motif containing 13 | 2 | 2 | ||||||||
MIRT522461 | MMP16 | matrix metallopeptidase 16 | 2 | 4 | ||||||||
MIRT547116 | PHLPP2 | PH domain and leucine rich repeat protein phosphatase 2 | 2 | 2 | ||||||||
MIRT548675 | CRNKL1 | crooked neck pre-mRNA splicing factor 1 | 2 | 2 | ||||||||
MIRT553756 | TARBP2 | TARBP2, RISC loading complex RNA binding subunit | 2 | 4 | ||||||||
MIRT559437 | ARSJ | arylsulfatase family member J | 2 | 2 | ||||||||
MIRT610490 | GPC4 | glypican 4 | 2 | 2 | ||||||||
MIRT644682 | TMCO1 | transmembrane and coiled-coil domains 1 | 2 | 2 | ||||||||
MIRT658214 | FBXO21 | F-box protein 21 | 2 | 2 | ||||||||
MIRT756083 | TP53 | tumor protein p53 | 4 | 1 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|